Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis

Metformin has been suggested to reduce thyroid cancer incidence and to improve thyroid cancer prognosis. We aimed to evaluate the associations between metformin and thyroid cancer incidence and prognosis (metastasis/recurrence/progression-free survival). Cochrane Library, PubMed, ClinicalTrials.gov,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zikun, Luo, Juhua, Zhang, Yijia, Xun, Pengcheng, Chen, Zhongxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333305/
https://www.ncbi.nlm.nih.gov/pubmed/35901016
http://dx.doi.org/10.1371/journal.pone.0271038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333305/
https://www.ncbi.nlm.nih.gov/pubmed/35901016
http://dx.doi.org/10.1371/journal.pone.0271038

Ejemplares similares